EB
Ecovia Bio
Summary
Ecovia Bio, a Michigan-based biotechnology spinout, closed a Series B round to expand its manufacturing capacity for sustainable biopolymer ingredients. The funding is targeted at scaling production for its biodegradable gamma polyglutamic acid technology.
Investors
Pointe Angels